Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Krystal Biotech Appoints Laurent Goux as General Manager of Europe

Krystal Biotech, Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced the appointment of Laurent Goux as the General Manager of Europe. Mr. Goux has...

KRYS : 57.76 (+4.11%)
Krystal Biotech to Present Data on DEB and B-VEC at the DEBRA International Conference 2021

-- U.S. FDA has recently approved a compassionate use request for topical B-VEC application to one eye in a RDEB patient

KRYS : 57.76 (+4.11%)
Krystal Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual...

KRYS : 57.76 (+4.11%)
Krystal Biotech Reports Second Quarter 2021 Financial Results and Provides Update on Operational Progress

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today reported financial results and key operational progress updates for the second quarter...

KRYS : 57.76 (+4.11%)
Jeune Aesthetics Announces Initiation of Dosing in Efficacy Cohort of KB301 Phase 1 trial to Assess Improvement in Skin Quality

Jeune Aesthetics, Inc., a wholly-owned subsidiary of Krystal Biotech, Inc., ("Krystal") (NASDAQ: KRYS) today announced the initiation of dosing in the efficacy cohort of the PEARL-1 trial, a Phase 1 multi-dose,...

KRYS : 57.76 (+4.11%)
Relative Strength Alert For Krystal Biotech

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

KRYS : 57.76 (+4.11%)
New Strong Sell Stocks for June 8th

ASLN, CANG, ESLT, GCI, and KRYS have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2021.

GCI : 6.83 (+1.64%)
ESLT : 146.72 (+0.42%)
KRYS : 57.76 (+4.11%)
CANG : 4.25 (+2.41%)
ASLN : 3.24 (+3.51%)
Krystal Biotech to Participate in Upcoming Investor Conferences

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced participation in two upcoming virtual investor conferences.

KRYS : 57.76 (+4.11%)
New Strong Sell Stocks for May 28th

ACET, FURY, KRYS, MRSN, and NBEV have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2021

ACET : 7.28 (+3.85%)
NBEV : 1.4700 (+0.68%)
KRYS : 57.76 (+4.11%)
MRSN : 9.82 (+2.19%)
FURY : 0.6300 (-6.31%)
New Strong Sell Stocks for May 21st

ATHM, INVO, FOUR, KRYS, and RMAX have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2021

RMAX : 31.50 (+0.80%)
ATHM : 41.27 (+0.36%)
KRYS : 57.76 (+4.11%)
INVO : 3.28 (-1.50%)
FOUR : 87.00 (+3.55%)

Barchart Exclusives

Platinum- The Not So Precious Metal That Loves To Disappoint
This week, platinum probed below the $900 per ounce level for the first time in 2021. While platinum is the precious metal that offers the most compelling value proposition, the price action remains bearish in late September. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar